Poonawalla Fincorp sells controlling stake in housing finance arm to Singapore company for Rs 3,004 crore
The Cyrus Poonawalla Group, more known for its vaccine-making business under the Serum Institute, in a statement said the financial consideration of Rs 3,004 crore is excluding the tax outgoes. With this sale, Poonawalla Housing Finance will cease to be a subsidiary of Poonawalla Fincorp, and Perseus will be holding a controlling stake.
The Insiders
0
6
The Cyrus Poonawalla Group, more known for its vaccine-making business under the Serum Institute, in a statement said the financial consideration of Rs 3,004 crore is excluding the tax outgoes. With this sale, Poonawalla Housing Finance will cease to be a subsidiary of Poonawalla Fincorp, and Perseus will be holding a controlling stake.
){kind=small}
